28056087|t|MITA/STING and Its Alternative Splicing Isoform MRP Restrict Hepatitis B Virus Replication
28056087|a|An efficient clearance of hepatitis B virus (HBV) requires the coordinated work of both the innate and adaptive immune responses. MITA/STING, an adapter protein of the innate immune signaling pathways, plays a key role in regulating innate and adaptive immune responses to DNA virus infection. Previously, we identified an alternatively spliced isoform of MITA/STING, called MITA-related protein (MRP), and found that MRP could specifically block MITA -mediated interferon (IFN) induction while retaining the ability to activate NF-κB. Here, we asked whether MITA/STING and MRP were able to control the HBV replication. Both MITA/STING and MRP significantly inhibited HBV replication in vitro. MITA overexpression stimulated IRF3 - IFN pathway; while MRP overexpression activated NF-κB pathway, suggesting these two isoform s may inhibit HBV replication through different ways. Using a hydrodynamic injection (HI) mouse model, we found that HBV replication was reduced following MITA/STING and MRP expression vectors in mice and was enhanced by the knockout of MITA/STING (MITA/STING-/-). The HBV specific humoral and CD8+ T cell responses were impaired in MITA/STING deficient mice, suggesting the participation of MITA/STING in the initiation of host adaptive immune responses. In summary, our data suggest that MITA/STING and MRP contribute to HBV control via modulation of the innate and adaptive responses.
28056087	0	10	MITA/STING	T116,T123	C2605778
28056087	19	39	Alternative Splicing	T045	C0002345
28056087	40	47	Isoform	T116	C0597298
28056087	48	51	MRP	T116,T123	C0033684
28056087	52	60	Restrict	T169	C0443288
28056087	61	78	Hepatitis B Virus	T005	C0019169
28056087	79	90	Replication	T043	C0042774
28056087	94	103	efficient	T080	C0442799
28056087	104	113	clearance	T080	C0449297
28056087	117	134	hepatitis B virus	T005	C0019169
28056087	136	139	HBV	T005	C0019169
28056087	183	189	innate	T032	C0020969
28056087	194	219	adaptive immune responses	T043	C1155229
28056087	221	231	MITA/STING	T116,T123	C2605778
28056087	236	251	adapter protein	T116,T123	C1449886
28056087	259	272	innate immune	T032	C0020969
28056087	273	291	signaling pathways	T044	C0037080
28056087	313	323	regulating	T038	C1327622
28056087	324	330	innate	T032	C0020969
28056087	335	360	adaptive immune responses	T043	C1155229
28056087	364	383	DNA virus infection	T047	C0012922
28056087	400	410	identified	T080	C0205396
28056087	414	435	alternatively spliced	T045	C0002345
28056087	436	443	isoform	T116	C0597298
28056087	447	457	MITA/STING	T116,T123	C2605778
28056087	466	486	MITA-related protein	T116,T123	C0033684
28056087	488	491	MRP	T116,T123	C0033684
28056087	509	512	MRP	T116,T123	C0033684
28056087	532	537	block	T169	C0332206
28056087	538	542	MITA	T116,T123	C2605778
28056087	553	563	interferon	T116,T121,T129	C0021747
28056087	565	568	IFN	T116,T121,T129	C0021747
28056087	570	579	induction	T169	C0205263
28056087	611	619	activate	T052	C1879547
28056087	620	625	NF-κB	T045	C1513838
28056087	650	660	MITA/STING	T116,T123	C2605778
28056087	665	668	MRP	T116,T123	C0033684
28056087	682	689	control	T169	C2587213
28056087	694	697	HBV	T005	C0019169
28056087	698	709	replication	T043	C0042774
28056087	716	726	MITA/STING	T116,T123	C2605778
28056087	731	734	MRP	T116,T123	C0033684
28056087	749	758	inhibited	T052	C3463820
28056087	759	762	HBV	T005	C0019169
28056087	763	774	replication	T043	C0042774
28056087	785	789	MITA	T116,T123	C2605778
28056087	790	804	overexpression	T045	C1171362
28056087	805	815	stimulated	T052	C1879547
28056087	816	820	IRF3	T116,T123	C1510506
28056087	823	826	IFN	T116,T121,T129	C0021747
28056087	827	834	pathway	T044	C1512834
28056087	842	845	MRP	T116,T123	C0033684
28056087	846	860	overexpression	T045	C1171362
28056087	861	870	activated	T052	C1879547
28056087	871	884	NF-κB pathway	T045	C1513838
28056087	907	914	isoform	T116	C0597298
28056087	921	928	inhibit	T052	C3463820
28056087	929	932	HBV	T005	C0019169
28056087	933	944	replication	T043	C0042774
28056087	977	999	hydrodynamic injection	T074	C3504436
28056087	1001	1003	HI	T074	C3504436
28056087	1005	1016	mouse model	T050	C2986594
28056087	1032	1035	HBV	T005	C0019169
28056087	1036	1047	replication	T043	C0042774
28056087	1052	1059	reduced	T080	C0392756
28056087	1070	1080	MITA/STING	T116,T123	C2605778
28056087	1085	1088	MRP	T116,T123	C0033684
28056087	1089	1107	expression vectors	T114	C0599566
28056087	1111	1115	mice	T015	C0025929
28056087	1124	1132	enhanced	T052	C2349975
28056087	1140	1148	knockout	T050	C1522225
28056087	1152	1162	MITA/STING	T028	C1823437
28056087	1164	1177	MITA/STING-/-	T028	C1823437
28056087	1184	1187	HBV	T005	C0019169
28056087	1197	1204	humoral	T043	C1155229
28056087	1209	1230	CD8+ T cell responses	T043	C3155011
28056087	1236	1244	impaired	T169	C0221099
28056087	1248	1258	MITA/STING	T028	C1823437
28056087	1259	1273	deficient mice	T015	C0206745
28056087	1307	1317	MITA/STING	T116,T123	C2605778
28056087	1325	1335	initiation	T169	C1704686
28056087	1339	1343	host	T001	C1167395
28056087	1344	1369	adaptive immune responses	T043	C1155229
28056087	1374	1381	summary	T170	C1706244
28056087	1387	1391	data	T078	C1511726
28056087	1405	1415	MITA/STING	T116,T123	C2605778
28056087	1420	1423	MRP	T116,T123	C0033684
28056087	1438	1441	HBV	T005	C0019169
28056087	1442	1449	control	T169	C2587213
28056087	1454	1464	modulation	UnknownType	C0678672
28056087	1472	1478	innate	T032	C0020969
28056087	1483	1501	adaptive responses	T043	C1155229